China-based startup Abogen Biosciences, a clinical-stage biotechnology group pioneering RNA innovation, has entered into a ...

Docquity, the Singapore-based clinical AI platform for more than 75% of verified doctors across Asia, has announced its scale ...

BioJapan 2026, Regenerative Medicine JAPAN and healthTECH JAPAN, PACIFICO Yokohama, 7 to 9 October Forty years after its first edition in 1986, BioJapan opened its 2026 edition at PACIFICO Yokohama on ...

AstraZeneca has announced the opening of its newest global strategic research and development (R&D) centre, in Kendall Square, Cambridge, Massachusetts, US.

NUS launches S$50M National Centre for Engineering Biology to accelerate AI-guided sustainable biomanufacturing ...

Germfree has launched a configurable Grade A aseptic biopharmaceutical isolator designed to support contamination control and ...

Australia's CSL inks $1.2 B deal with Swiss firm Alentis to develop lixudebart for rare kidney and liver diseases treatment ...

Hengrui Pharma and Novo Enter ink $2.6billion deal for Once-Weekly Oral GLP-1/GIP Dual Receptor Agonist HRS-1596 ...

Hnin Yin Yin NYEIN from the Department of Chemical and Biological Engineering at The Hong Kong University of Science and ...

Vitalant has opened a cell-based analytics laboratory at the Phoenix Bioscience Core to expand donor characterisation, immune profiling and assay-development support for allogeneic therapy developers.

Terumo BCT, TrAMPoline Pharma and the University of Colorado are collaborating to automate manufacturing of genetically enhanced TIL therapies using the Quantum Flex Cell Expansion System.

Merck, known as MSD outside of the United States and Canada, and China-based startup SciBrunch Therapeutics have entered into an exclusive global license agreement for SPR2015, an investigational ...